GnRH Analogs in Contraception

  • Regine Sitruk-Ware
Part of the Progress in Vaccinology book series (VACCINOLOGY, volume 1)

Abstract

We are fast approaching an era in which “zero population growth” will be a vital necessity rather than merely a desirable alternative. Reducing the millions of unplanned and unwanted pregnancies worldwide would solve many economic and health problems and would enable developing countries, particularly, to improve their standard of living (29).

Keywords

Toxicity Ethyl Estrogen Osteoporosis Amide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bergquist C, Nillius SJ, Wide L: Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist. Contraception 1979; 19:497.PubMedCrossRefGoogle Scholar
  2. 2.
    Bergquist C, Nillius SJ, Wide L: Reduced gonadotropin secretion in post menopausal women during treatment with a stimulatory LHRH analogue. J Clin Endocrinol Metab 1979;49:472.PubMedCrossRefGoogle Scholar
  3. 3.
    Bergquist C, Nillius SJ, Wide L: Luteolysis induced by a luteinizing hormone releasing hormone agonist is prevented by human chronic gonadotropin. Contraception 1980;22:341.PubMedCrossRefGoogle Scholar
  4. 4.
    Bergquist C, Nillius SJ, Wide L, et al: Endometrial patterns in women on chronic LHRH agonist treatment for inhibition of ovulation. Fertil Steril 1981:36:339.PubMedGoogle Scholar
  5. 5.
    Bergquist C, Nillius SJ, Wide L: Failure of positive feedback of Oestradiol during chronic intranasal luteinizing hormone releasing hormone agonist treatment. Clin Endocrinol 1982; 16:147.CrossRefGoogle Scholar
  6. Bouchard P, Blondet C, Spitz I, et al: Sperm supression by long acting GnRH agonist therapy in men: critical effect of testosterone substitution and duration of therapy. 68th Annual meeting of the Endocrine Society, Anaheim. Abstract 498.Google Scholar
  7. 7.
    Casper RF, Yen SSC: Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor. Science 1979;205:408.PubMedCrossRefGoogle Scholar
  8. 8.
    Casper RF, Eriksson GF, Rebar RW, et al: The effect of luteinizing hormone-releasing factor and its agonist on cultured human granulosa cells. Fertil Steril 1982;37:406.PubMedGoogle Scholar
  9. 9.
    Casper RF, Sheehan KL, Yen SSC: Chorionic gonadotropin prevents LRH agonist-induced luteolysis in the human. Contraception 1980;21:471.PubMedCrossRefGoogle Scholar
  10. 10.
    Clayton RN: Gonadotropin-releasing hormone modulation of its own pituitary receptors: Evidence for biphasic regulation. Endocrinology 1982; 152:161.Google Scholar
  11. 11.
    Clayton RN, Call KJ: Receptor binding affinity of gonadotropin releasing hormone analogs: analysis by radioligand-receptor assay. Endocrinology 1980; 106:1154.PubMedCrossRefGoogle Scholar
  12. 12.
    Clayton RN, Huhtaniemi IT; Absence of gonadotropin-releasing hormone receptors in human gonadal tissue. Nature (London) 1982;299:56.CrossRefGoogle Scholar
  13. 13.
    Coy DH, Labrie F, Savary M, et al: LH-releasing activity of potent LHRH analogs in vitro. Biochem Biophys Res Commun 1975;67:576.PubMedCrossRefGoogle Scholar
  14. 14.
    Coy DH, Vilchez-Martinez JA, Coy EJ, et al: Analogs of luteinizing hormone-releasing hormone with increased biological activity produced by D, amino acid substitutions in position 6, J Med Chem 1976; 19:423.PubMedCrossRefGoogle Scholar
  15. 15.
    Das C, Talwar GP: Pregnancy terminating action of a luteinizing hormone releasing hormone agonist D-Ser(But)6 des GlylO Pro EA in baboons. Fert H Steril 1983;39:218.Google Scholar
  16. 16.
    Duello TM, Nett TM, Farquhar MG: Fate of a gonadotropin-releasing hormone agonist internalized by rat pituitary gonadotrophs. Endocrinology 1983; 112:1.PubMedCrossRefGoogle Scholar
  17. 17.
    Fräser H, Baird ITT, McRae GI, et al: Suppression of luteal progesterone secretion in the stumptailed macaque by an antagonistic analogue of luteinizing hormone-releasing hormone. J Endocrinol 1985;104: R1.PubMedCrossRefGoogle Scholar
  18. 18.
    Hazum E, Keinand D: Gonadotropin releasing-hormone receptors: photo affinity labeling with an antagonist. Biochem Biophys Res Com 1983; 110:116.PubMedCrossRefGoogle Scholar
  19. 19.
    Knobil E: The neuro-endocrine control of the menstrual cycle. Recent Prog Horm Res 1980;36:53.PubMedGoogle Scholar
  20. 20.
    Lemay A, Faure N, Labrie F, et al: Inhibition of ovulation during discontinuous intranasal luteinizing hormone-relea sing hormone agonist dosing in combination with gestagen-induced bleeding, Fertil Steril 1985;43:868.PubMedGoogle Scholar
  21. 21.
    Lemay A, Labrie F, Belanger A, et al: Luteolytic effect of intranasal administration of (D-Ser(TBU)6,DES-GLY-NH2 10)- luteinizing hormonereleasing hormone ethylamide in normal women. Fertil Steril 1979;32:646.PubMedGoogle Scholar
  22. 22.
    Linde R, Doelle GC, Alexander N, et al: Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent go nadotrop in-releasing hormone agonist in normal men. N Engl J Med 1981;305:663.PubMedCrossRefGoogle Scholar
  23. 23.
    Loumaye E, Catt KJ: Homologous regulation of gonadotropin-releasing hormone receptors in cultured pituitary cells. Science 1982;215:983.PubMedCrossRefGoogle Scholar
  24. 24.
    Nestor JJ Jr: Development of agonist LH RH analogs, in Vickery BH, Nestor JJ Jr, Hafez ESE (eds): LH RH and Its Analogs: Contraceptive and Therapeutic Applications. Boston, MTP Press, 1984, p 3.Google Scholar
  25. 25.
    Nieschlag E, Akhtar FB, Weinbauer GF, et al: LHRH analogues for male fertility control: experiments in monkeys and men. J Steroid Biochem 1984:20:1374.CrossRefGoogle Scholar
  26. 26.
    Nillius SJ, Berguist C, Wide L: Inhibition of ovulation in women by chronic treatment with a stimulatory LHRH analogue. A new approach to birth control? Contraception 1978;17:537.CrossRefGoogle Scholar
  27. 27.
    Rajfer J, Swerdloff RS, Heber DM: Testicular histology following chronic GnRH agonist treatment. Fertil Steril 1984;42:765.PubMedGoogle Scholar
  28. 28.
    Rivier C, Rivier J, Vale N: Antireproductive effects of a potent GnRH antagonist in the female rat. Endocrinology 1981; 108:1425.PubMedCrossRefGoogle Scholar
  29. 29.
    Schally AV: Research frontiers in fertility regulation. PARFR 1983;2:1.Google Scholar
  30. 30.
    Schally AV, Arimura A, Baba Y, et al: Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun 1971;43:393.PubMedCrossRefGoogle Scholar
  31. 31.
    Schally AV, Arimura A, Kastin AJ, et al: Gonadotropin releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science 1971;173:1036.PubMedCrossRefGoogle Scholar
  32. 32.
    Schally AV, Nair RMG, Redding TW, et al: Isolation of the luteinizing hormone and follicle-stimulating hormone-re leasing hormone from porcine hypothalami. J Biol Chem 1971;246:7230.PubMedGoogle Scholar
  33. 33.
    Schally AV, Redding TW: Combination of long-acting micro capsules of the Dtryptophan-6analog of luteinizing hormone-releasing hormone with chemotherapy; investigation in the rat prostate cancer model, Proc Natl Acad Sci USA 1985;82:2498.Google Scholar
  34. 34.
    Sheehan KL, Casper RF, Yen SSC: Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility and reversibility. Fertil Steril 1982;36:664.Google Scholar
  35. 35.
    Sciarra JJ: The continuing need for contraceptive research. Fertil Steril 1981;36:697.PubMedGoogle Scholar
  36. 36.
    Tolis G, Comaru-Schally AM, Mehta AE, et al: Failure to interrupt established pregnancy in humans by D-tryptophan-6-luteinizing-hormone-releasing hormone. Fertil Steril 1981;36:241.PubMedGoogle Scholar
  37. 37.
    Vickery BH: Comparison of the potential for therapeutic utilities with gonadotropinreleasing hormone Agonists and Antagonists. Endocrine Rev 1986;7:115.CrossRefGoogle Scholar
  38. 38.
    Weinbauer GF, Surmann FJ, Akhtar FB, et al: Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis). Fertil Steril 1985;42:906.Google Scholar
  39. 39.
    Wilks JW, Folkers K, Smith CW: Activities of LHRH antagonists in rhesus monkeys during the periovulatory interval of the menstrual cycle and early pregnancy, in Zatuchni GI, Shelton JD, Sciarra JJ (eds): LHRH Peptides as Female and Male Contraceptives. Philadelphia, Harper & Row, 1981, p 151.Google Scholar
  40. 40.
    Zarate A, Canales E, Schally AV, et al: The use of LHRH agonists and antagonists as antifertility agents in the human female, in Zatuchni GL Shelton JD, Sciarra JJ (eds): LHRH Peptides as Female and Male Contraceptives. Philadelphia, Harper & Row, 1981, p 221.Google Scholar
  41. 41.
    Zarate A, Canales ES, Sthory I, et al: Anovulatory effect of a LHRH antagonist in women. Contraception 1981;24:315–320.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1988

Authors and Affiliations

  • Regine Sitruk-Ware

There are no affiliations available

Personalised recommendations